Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaurav Goyal

Showing results (131-140 of 186) with videos related to

Pageof 19
Sort By:
Haematologica|December 7, 2022
Sirolimus as frontline therapy for <i>PTEN</i>-mutated histiocytic sarcomaKaran L Chohan, Jithma P Abeykoon, Jason R Young, et al.
Blood|March 31, 2026
International Expert Recommendations for the Diagnosis and Treatment of Malignant Histiocytic NeoplasmsGaurav Goyal, Oussama Abla, John K C Chan, et al.
British Journal of Haematology|November 20, 2021
Mimics of Erdheim-Chester diseaseJithma P Abeykoon, Aishwarya Ravindran, Karen L Rech, et al.
Blood|January 31, 2019
Tumor mutational burden and other predictive immunotherapy markers in histiocytic neoplasmsGaurav Goyal, Denise Lau, Alison M Nagle, et al.
Haematologica|April 21, 2019
Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman diseaseGaurav Goyal, Aishwarya Ravindran, Jason R Young, et al.
Leukemia & Lymphoma|July 2, 2020
Low-dose vemurafenib monotherapy in <i>BRAF</i> -mutated Erdheim-Chester diseaseGordon J Ruan, Antonious Hazim, Jithma P Abeykoon, et al.
Blood Cancer Journal|June 28, 2022
Clinical and therapeutic implications of BRAF fusions in histiocytic disordersSaurabh Zanwar, Jithma P Abeykoon, Surendra Dasari, et al.
Haematologica|May 25, 2019
Erdheim-Chester disease with concomitant Rosai-Dorfman like lesions: a distinct entity mainly driven by <i>MAP2K1</i>Jérôme Razanamahery, Eli L Diamond, Fleur Cohen-Aubart, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 18, 2020
Highlights of the Management of Adult Histiocytic Disorders: Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Rosai-Dorfman Disease, and Hemophagocytic LymphohistiocytosisHind Abdin Salama, Abdul Rahman Jazieh, Ayman Yahya Alhejazi, et al.
The Oncologist|September 28, 2020
Efficacy of BRAF-Inhibitor Therapy in BRAF<sup>V600E</sup> -Mutated Adult Langerhans Cell HistiocytosisAntonious Z Hazim, Gordon J Ruan, Aishwarya Ravindran, et al.
Pageof 19

Showing results (131-140 of 186) with videos related to

Sort By:
Pageof 19
Haematologica|December 7, 2022
Sirolimus as frontline therapy for <i>PTEN</i>-mutated histiocytic sarcomaKaran L Chohan, Jithma P Abeykoon, Jason R Young, et al.
Blood|March 31, 2026
International Expert Recommendations for the Diagnosis and Treatment of Malignant Histiocytic NeoplasmsGaurav Goyal, Oussama Abla, John K C Chan, et al.
British Journal of Haematology|November 20, 2021
Mimics of Erdheim-Chester diseaseJithma P Abeykoon, Aishwarya Ravindran, Karen L Rech, et al.
Blood|January 31, 2019
Tumor mutational burden and other predictive immunotherapy markers in histiocytic neoplasmsGaurav Goyal, Denise Lau, Alison M Nagle, et al.
Haematologica|April 21, 2019
Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman diseaseGaurav Goyal, Aishwarya Ravindran, Jason R Young, et al.
Leukemia & Lymphoma|July 2, 2020
Low-dose vemurafenib monotherapy in <i>BRAF</i> -mutated Erdheim-Chester diseaseGordon J Ruan, Antonious Hazim, Jithma P Abeykoon, et al.
Blood Cancer Journal|June 28, 2022
Clinical and therapeutic implications of BRAF fusions in histiocytic disordersSaurabh Zanwar, Jithma P Abeykoon, Surendra Dasari, et al.
Haematologica|May 25, 2019
Erdheim-Chester disease with concomitant Rosai-Dorfman like lesions: a distinct entity mainly driven by <i>MAP2K1</i>Jérôme Razanamahery, Eli L Diamond, Fleur Cohen-Aubart, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 18, 2020
Highlights of the Management of Adult Histiocytic Disorders: Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Rosai-Dorfman Disease, and Hemophagocytic LymphohistiocytosisHind Abdin Salama, Abdul Rahman Jazieh, Ayman Yahya Alhejazi, et al.
The Oncologist|September 28, 2020
Efficacy of BRAF-Inhibitor Therapy in BRAF<sup>V600E</sup> -Mutated Adult Langerhans Cell HistiocytosisAntonious Z Hazim, Gordon J Ruan, Aishwarya Ravindran, et al.
Pageof 19